BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 15951732)

  • 1. Erectile dysfunction: molecular biology, pathophysiology and pharmacological treatment.
    Morelli A; Vignozzi L; Filippi S; Mancina R; Maggi M
    Minerva Urol Nefrol; 2005 Jun; 57(2):85-90. PubMed ID: 15951732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral regulatory mechanisms in erection.
    Morelli A; Filippi S; Zhang XH; Luconi M; Vignozzi L; Mancina R; Maggi M
    Int J Androl; 2005 Dec; 28 Suppl 2():23-7. PubMed ID: 16236060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide-cyclic GMP pathway with some emphasis on cavernosal contractility.
    Ghalayini IF
    Int J Impot Res; 2004 Dec; 16(6):459-69. PubMed ID: 15229623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphodiesterase 5 mechanisms and therapeutic applications.
    Burnett AL
    Am J Cardiol; 2005 Dec; 96(12B):29M-31M. PubMed ID: 16387563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic strategies for optimizing PDE-5 inhibitor therapy in patients with erectile dysfunction considered difficult or challenging to treat.
    de Tejada IS
    Int J Impot Res; 2004 Jun; 16 Suppl 1():S40-2. PubMed ID: 15224136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Chaga Medicinal Mushroom Inonotus obliquus (Agaricomycetes) Extracts on NOS-cGMP-PDE5 Pathway in Rat Penile Smooth Muscle Cells.
    Liao H; Jia D; Zhao X; Zheng D; Li Y; Li R
    Int J Med Mushrooms; 2020; 22(10):979-990. PubMed ID: 33426827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The therapeutic dilemma: how to use short-acting PDE5 inhibitor drugs.
    Fabbri A; Aversa A
    Int J Androl; 2005 Dec; 28 Suppl 2():69-73. PubMed ID: 16236069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction.
    Boolell M; Allen MJ; Ballard SA; Gepi-Attee S; Muirhead GJ; Naylor AM; Osterloh IH; Gingell C
    Int J Impot Res; 1996 Jun; 8(2):47-52. PubMed ID: 8858389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of action of PDE5 inhibition in erectile dysfunction.
    Corbin JD
    Int J Impot Res; 2004 Jun; 16 Suppl 1():S4-7. PubMed ID: 15224127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evolving role of testosterone in the treatment of erectile dysfunction.
    Shabsigh R; Rajfer J; Aversa A; Traish AM; Yassin A; Kalinchenko SY; Buvat J
    Int J Clin Pract; 2006 Sep; 60(9):1087-92. PubMed ID: 16939550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphodiesterase type 5 inhibitors for erectile dysfunction.
    Carson CC; Lue TF
    BJU Int; 2005 Aug; 96(3):257-80. PubMed ID: 16042713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of penile erection and basis for pharmacological treatment of erectile dysfunction.
    Andersson KE
    Pharmacol Rev; 2011 Dec; 63(4):811-59. PubMed ID: 21880989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone therapy in erectile dysfunction and hypogonadism.
    Shabsigh R
    J Sex Med; 2005 Nov; 2(6):785-92. PubMed ID: 16422803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chinese herbal drugs for erectile dysfunction through NO-cGMP-PDE5 signaling pathway].
    Liao H; Jacob R
    Zhonghua Nan Ke Xue; 2012 Mar; 18(3):260-5. PubMed ID: 22474995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Androgen deficiency and erectile dysfunction].
    Pan LJ; Xia XY; Huang YF
    Zhonghua Nan Ke Xue; 2006 Nov; 12(11):1030-4. PubMed ID: 17146934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes exacerbates the functional deficiency of NO/cGMP pathway associated with erectile dysfunction in human corpus cavernosum and penile arteries.
    Angulo J; González-Corrochano R; Cuevas P; Fernández A; La Fuente JM; Rolo F; Allona A; Sáenz de Tejada I
    J Sex Med; 2010 Feb; 7(2 Pt 1):758-68. PubMed ID: 19912487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of sildenafil citrate (Viagra) and tadalafil (Cialis) on sexual responses in Saudi men with erectile dysfunction in routine clinical practice.
    Ali ST
    Pak J Pharm Sci; 2008 Jul; 21(3):275-81. PubMed ID: 18614424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide and penile erectile function.
    Toda N; Ayajiki K; Okamura T
    Pharmacol Ther; 2005 May; 106(2):233-66. PubMed ID: 15866322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic inhibition of nitric-oxide synthase induces hypertension and erectile dysfunction in the rat that is not reversed by sildenafil.
    Gur S; Kadowitz PJ; Gurkan L; Chandra S; Dewitt SY; Harbin A; Sikka SC; Agrawal KC; Hellstrom WJ
    BJU Int; 2010 Jul; 106(1):78-83. PubMed ID: 20002674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent insights into androgen action on the anatomical and physiological substrate of penile erection.
    Gooren LJ; Saad F
    Asian J Androl; 2006 Jan; 8(1):3-9. PubMed ID: 16372114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.